Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide

Basit Öğe Kaydı
dc.contributor.authorYilmaz, N.
dc.contributor.authorEmmungil, H.
dc.contributor.authorGucenmez, S.
dc.contributor.authorOzen, G.
dc.contributor.authorYildiz, F.
dc.contributor.authorBalkarli, A.
dc.contributor.authorKimyon, G.
dc.date.accessioned2020-03-26T19:06:18Z
dc.date.available2020-03-26T19:06:18Z
dc.date.issued2015
dc.departmentSelçuk Üniversitesien_US
dc.description11th International Congress on Systemic Lupus Erythematosus -- SEP 02-06, 2015 -- Vienna, AUSTRIAen_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.endpageS67en_US
dc.identifier.issn0392-856Xen_US
dc.identifier.issn1593-098Xen_US
dc.identifier.issue3en_US
dc.identifier.startpageS67en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/32310
dc.identifier.volume33en_US
dc.identifier.wosWOS:000360421900240en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherCLINICAL & EXPER RHEUMATOLOGYen_US
dc.relation.ispartofCLINICAL AND EXPERIMENTAL RHEUMATOLOGYen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleMalignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamideen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu